Viking Therapeutics, Inc Share Price
NASDAQ: VKTXHealthcare
Live Viking Therapeutics, Inc Share Price Chart
O H L
Viking Therapeutics, Inc Performance Overview
Days Range
▼
$30.00Low
$30.50High
Markets Today
| Previous Close | $29.52 |
|---|---|
| Open | $30.26 |
| Volume | 475,735 |
| Day's Range | $30.00 - $30.50 |
| 52W Range | $22.96 - $43.15 |
| Market Cap | $3.49 B |
Historical Performance
| 1M Returns | -12.22 |
|---|---|
| 3M Returns | -2.54 |
| 6M Returns | -16.92 |
| 1Y Returns | +27.85 |
| 5Y Returns | +341.26 |
| 10Y Returns | +2206.25 |
Viking Therapeutics, Inc Fundamentals
| Market Cap | $3.49 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.47 |
| EPS TTM | $-4.66 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 8.56 |
| EBITDA | $-393.34 M |
| Profit Margin | N/A |
| Market Cap | $3.49 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.47 |
| EPS TTM | $-4.66 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 8.56 |
| EBITDA | $-393.34 M |
| Profit Margin | N/A |
Viking Therapeutics, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$55.47 M | -$74.57 M | -$98.56 M | -$164.74 M | -$164.13 M | -$132.60 M |
| EBITDA | -$55.47 M | -$74.57 M | -$98.56 M | -$164.74 M | -$164.13 M | -$132.60 M |
| Interest Expense | $0 | $0 | -$8.00 K | $56.00 K | $0 | $0 |
| Depreciation | $0 | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$45.63 M | -$65.56 M | -$90.79 M | -$157.66 M | -$158.32 M | -$128.02 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$45.63 M | -$65.56 M | -$90.79 M | -$157.66 M | -$158.32 M | -$128.02 M |
| Net Profit Margin | - | - | - | - | - | - |
Viking Therapeutics, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K |
| Reserve & Surplus | -$533.75 M | -$599.10 M | -$689.88 M | -$847.55 M | -$1.01 B | -$1.13 B |
| Non-Current Liabilities | $502.00 K | $410.00 K | $318.00 K | $0 | $0 | $3.92 M |
| Current Liabilities | $19.57 M | $31.98 M | $26.07 M | $76.67 M | $106.33 M | $109.66 M |
| Total Liabilities | $20.07 M | $32.39 M | $26.39 M | $76.67 M | $106.33 M | $113.58 M |
| Fixed Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Assets | $866.02 M | $827.02 M | $738.70 M | $715.60 M | $608.21 M | $517.56 M |
| Total Assets | $866.99 M | $827.85 M | $739.41 M | $715.73 M | $608.24 M | $521.90 M |
Viking Therapeutics, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$45.63 M | -$65.56 M | -$90.79 M | -$157.66 M | -$158.32 M | -$128.02 M |
| Operating Cash Flow | -$52.33 M | -$47.06 M | -$94.00 M | -$85.29 M | -$113.98 M | -$125.17 M |
| Investing Cash Flow | $63.24 M | $42.51 M | $160.03 M | $75.61 M | $54.19 M | $109.43 M |
| Financing Cash Flow | $349.00 K | $507.00 K | $480.00 K | $75.10 M | $12.08 M | $23.59 M |
| Change in Cash | $11.26 M | -$4.05 M | $66.50 M | $65.42 M | -$47.71 M | $7.84 M |
Viking Therapeutics, Inc Return Calculator
The Viking Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$45,142
Invested Amount$10,000
Est. Returns$35,142
About Viking Therapeutics, Inc
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Popular Stocks
FAQs
What is the share price of Viking Therapeutics, Inc today?
Viking Therapeutics, Inc (VKTX) share price as of September 17, 2026 is $30.20. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Viking Therapeutics, Inc?
Yes, Indian Investors can invest in the Viking Therapeutics, Inc (VKTX) Share by opening an international trading account with Angel One.
How can I purchase Viking Therapeutics, Inc shares in India?
Purchasing Viking Therapeutics, Inc (VKTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Viking Therapeutics, Inc (VKTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Viking Therapeutics, Inc?
Yes, you can purchase fractional shares of Viking Therapeutics, Inc (VKTX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Viking Therapeutics, Inc?
The market capitalization of Viking Therapeutics, Inc on September 17, 2026, is $3.49 B.
In which sector Viking Therapeutics, Inc belongs?
Viking Therapeutics, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Viking Therapeutics, Inc stocks?
In order to invest in Viking Therapeutics, Inc (VKTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
